More Chimeric Therapeutics Limited news Chimeric Therapeutics LimitedASX: CHM Chimeric opens CHM CDH17 Phase 1/2 trial May 22, 2024 at 4:35 AM UTC As issuedPlain English Chimeric Therapeutics Ltd has released a press release. View Attachment
